株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

中東11ヶ国の自動微生物検査市場の分析:サプライヤー戦略、検査件数・売上高予測

Middle East Automated Microbiology Market, 2019-2023:An 11-Country Analysis-Supplier Strategies, Volume & Sales Forecasts for 100 Molecular Diagnostic, Microbial Identification, Susceptibility, Blood Culture, Urine Screening & Immunodiagnostic Tests

発行 Venture Planning Group 商品コード 509953
出版日 ページ情報 英文 500 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.06円で換算しております。

Local License: 同一事業所内

Back to Top
中東11ヶ国の自動微生物検査市場の分析:サプライヤー戦略、検査件数・売上高予測 Middle East Automated Microbiology Market, 2019-2023:An 11-Country Analysis-Supplier Strategies, Volume & Sales Forecasts for 100 Molecular Diagnostic, Microbial Identification, Susceptibility, Blood Culture, Urine Screening & Immunodiagnostic Tests
出版日: ページ情報: 英文 500 Pages
概要

当レポートでは、中東11ヶ国の自動微生物検査市場について調査分析し、現在のサプライヤーと潜在的な市場参入企業に対する今後5年間の成長機会に焦点を当てて、国別分析、基準標本、適用、主要システム、技術、競合評価などについて、体系的な情報を提供しています。

第1章 イントロダクション

第2章 自動微生物検査市場のビジネス環境

第3章 新製品開発の機会

第4章 分散型検査製品の設計基準

第5章 代替的な市場普及戦略

第6章 潜在的な市場参入障壁とリスク

第7章 市場と技術の概要

  • イントロダクション
  • 主な基準標本
    • 尿
    • 無菌液
    • 咽頭スワブ、呼吸器分泌物
    • 生殖器分泌物
    • 便
    • 膿瘍/創傷
    • 唾液
  • 検査の適用
    • 微生物同定
    • 抗生物質感受性
    • 尿スクリーニング
    • 血液培養
  • 主な自動/半自動微生物検査システム
    • 一般微生物検査システム
    • 特殊微生物検査システム
    • 分子診断システム
    • 免疫診断システム
  • 新興の診断技術
    • 分子診断
    • モノクローナル抗体
    • イムノアッセイ (免疫測定法)
    • 差分光散乱
    • IT
    • AI (人工知能)
    • リポソーム
    • フローサイトメトリー
    • クロマトグラフィ
    • 画像診断
    • ゲル微液滴
    • その他

第8章 国別分析:売上高と件数予測 (分子診断、微生物同定、抗生物質感受性、血液培養、尿スクリーニング、免疫診断検査など) 、サプライヤーシェア

  • バーレーン
  • イラン
  • イラク
  • イスラエル
  • ヨルダン
  • クウェート
  • レバノン
  • オマーン
  • カタール
  • サウジアラビア
  • アラブ首長国連邦 (UAE)

第9章 競合評価

  • Abbott
  • Affymetrix/Thermo Fisher
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca Biopharma
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • bioMerieux
  • Bio-Rad
  • Biotest
  • CellMark Forensics/LabCorp
  • Cepheid
  • Decode
  • Diadexus
  • Diamedix
  • DiaSorin
  • 栄研化学
  • Elitech Group
  • Enzo Biochem
  • Exact Sciences
  • 富士レビオ
  • Grifols
  • Hologic/Gen-Probe
  • ID Biomedical/GSK
  • Illumina
  • Kreatech/Leica
  • Li-Cor Biosciences
  • Lonza
  • Monogram Biosciences
  • Myriad Genetics
  • Ortho-Clinical Diagnostics
  • Perkin Elmer/Caliper
  • Proteome Sciences
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • 島津製作所
  • Siemens
  • Sierra Molecular
  • タカラバイオ
  • Tecan
  • Wallac/PE
  • 和光純薬工業
目次
Product Code: VPAM37984

This new 11-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test.

The survey is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the automated microbiology market during the next five years. The report examines key trends; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for 100 molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.

Rationale

The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests. The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans. Some laboratorians still believe that current instrumentation is not the ultimate technology and expect better automation on the horizon.

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expense are coming under severe scrutiny worldwide.

This comprehensive 11-country survey will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology market, in evaluating emerging opportunities and developing effective business strategies.

Country Analyses

Bahrain, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, United Arab Emirates

Specimen Types

- Urine Sterile Fluids: Blood, Serum, CSF Throat Swabs, Respiratory Secretions Genital Secretions Stool Abscess/Wound Sputum Saliva

Applications

- Microbial Identification  Antibiotic Susceptibility  Urine Screening  Blood Cultures

Review of Major Automated Systems

- Review of major automated molecular diagnostic, multipurpose, specialized, microbial identification, antibiotic susceptibility, blood culture, urine screening, and immunodiagnostic analyzers marketed by Abbott, Alifax, BD, Beckman Coulter/Danaher, Biolog, bioMerieux, Bio-Rad, Cepheid, Curetis, GenMark, Hologic, HTG, Labsystems, Qiagen, Roche, Siemens Healthineers, Sy-Lab, Sysmex, Tecan, Thermo Fisher, Tosoh and other suppliers.

Infectious Diseases Analyzed in the Report

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme Disease, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.

Technology Review

- Assessment of molecular diagnostic, monoclonal antibody, immunoassay, and other technologies and their potential applications for the microbiology market.

- Companies developing or marketing microbiology products, by individual test.

Competitive Assessments

- Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.

Opportunities and Strategic Recommendations

- Emerging opportunities for new analyzers, reagents kits, IT and other products with significant market appeal during the next five years.

- Design criteria for decentralized testing products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Contains over 500 pages and 54 tables

Table of Contents

I. Introduction

II. Automated Microbiology Market Business Environment

III. New Product Development Opportunities

IV. Design Criteria for Decentralized Testing Products

V. Alternative Market Penetration Strategies

VI. Potential Market Entry Barriers and Risks

VII. Market and Technology Overview

  • A. Introduction
    • 1. Major Factors Affecting Market Penetration for Microbiology Instrumentation
    • 2. Traditional Practices
    • 3. Technological Challenges
    • 4. Automation: Impact on the Microbiology Laboratory and the Patient
  • B. Major Specimen Types
    • 1. Urine
    • 2. Sterile Fluids: Blood, Serum, and CSF
    • 3. Throat Swabs and Respiratory Secretions
    • 4. Genital Secretions
    • 5. Stool
    • 6. Abscess/Wound
    • 7. Sputum
    • 8. Saliva
  • C. Test Applications
    • 1. Microbial Identification
    • 2. Antibiotic Susceptibility
    • 3. Urine Screening
      • a. Photometry
      • b. Bioluminescence
      • c. Colorimetric Filtration
      • d. Enzymatic Detection
      • e. Optical Detection
    • 4. Blood Cultures
  • D. Major Automated and Semi-automated Microbiology Systems
    • 1. Multiple Purpose Microbiology Systems
    • 2. Specialized Microbiology Systems
    • 3. Molecular Diagnostic Systems
    • 4. Immunodiagnostic Systems
  • E. Emerging Diagnostic Technologies
    • 1. Molecular Diagnostics (Amplification Methods, Sequencing, Microarrays/Biochips)
      • a. DNA Sequencing
      • b. DNA and RNA Probe Technologies
      • c. Detection Technologies
      • d. Biochips: Genosensors, Microarrays, Labs-on-the-Chip
    • 2. Monoclonal Antibodies
    • 3. Immunoassays
    • 4. Differential Light Scattering
    • 5. Information Technology
    • 6. Artificial Intelligence
    • 7. Liposomes
    • 8. Flow Cytometry
    • 9. Chromatography
    • 10. Diagnostic Imaging
    • 11. Gel Microdroplets
    • 12. Other

VIII. Country Analyses: Sales and Volume Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests, Supplier Shares

  • Bahrain
  • Iran
  • Iraq
  • Israel
  • Jordan
  • Kuwait
  • Lebanon
  • Oman
  • Qatar
  • Saudi Arabia
  • United Arab Emirates

IX. Competitive Assessments

  • Abbott
  • Affymetrix/Thermo Fisher
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca Biopharma
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • bioMerieux
  • Bio-Rad
  • Biotest
  • CellMark Forensics/LabCorp
  • Cepheid
  • Decode
  • Diadexus
  • Diamedix
  • DiaSorin
  • Eiken Chemical
  • Elitech Group
  • Enzo Biochem
  • Exact Sciences
  • Fujirebio
  • Grifols
  • Hologic/Gen-Probe
  • ID Biomedical/GSK
  • Illumina
  • Kreatech/Leica
  • Li-Cor Biosciences
  • Lonza
  • Monogram Biosciences
  • Myriad Genetics
  • Ortho-Clinical Diagnostics
  • Perkin Elmer/Caliper
  • Proteome Sciences
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Shimadzu
  • Siemens
  • Sierra Molecular
  • Takara Bio
  • Tecan
  • Wallac/PE
  • Wako

List of Tables

  • Bahrain
  • Microbiology Specimen Volume Forecast by Type
  • Bahrain
  • Microbiology Test Volume Forecasts by Application
  • Bahrain
  • Microbiology Consumables Market Forecast by Application
  • Bahrain
  • Infectious Disease Test Volume Forecast by Assay
  • Bahrain
  • Infectious Disease Diagnostics Market Forecast by Test
  • Bahrain
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • Bahrain
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • Iran
  • Microbiology Specimen Volume Forecast by Type
  • Iran
  • Microbiology Test Volume Forecasts by Application
  • Iran
  • Microbiology Consumables Market Forecast by Application
  • Iran
  • Infectious Disease Test Volume Forecast by Assay
  • Iran
  • Infectious Disease Diagnostics Market Forecast by Test
  • Iran
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • Iran
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • Iraq
  • Microbiology Specimen Volume Forecast by Type
  • Iraq
  • Microbiology Test Volume Forecasts by Application
  • Iraq
  • Microbiology Consumables Market Forecast by Application
  • Iraq
  • Infectious Disease Test Volume Forecast by Assay
  • Iraq
  • Infectious Disease Diagnostics Market Forecast by Test
  • Iraq
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • Iraq
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • Israel
  • Microbiology Specimen Volume Forecast by Type
  • Israel
  • Microbiology Test Volume Forecasts by Application
  • Israel
  • Microbiology Consumables Market Forecast by Application
  • Israel
  • Infectious Disease Test Volume Forecast by Assay
  • Israel
  • Infectious Disease Diagnostics Market Forecast by Test
  • Israel
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • Israel
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • Jordan
  • Microbiology Specimen Volume Forecast by Type
  • Jordan
  • Microbiology Test Volume Forecasts by Application
  • Jordan
  • Microbiology Consumables Market Forecast by Application
  • Jordan
  • Infectious Disease Test Volume Forecast by Assay
  • Jordan
  • Infectious Disease Diagnostics Market Forecast by Test
  • Jordan
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • Jordan
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • Kuwait
  • Microbiology Specimen Volume Forecast by Type
  • Kuwait
  • Microbiology Test Volume Forecasts by Application
  • Kuwait
  • Microbiology Consumables Market Forecast by Application
  • Kuwait
  • Infectious Disease Test Volume Forecast by Assay
  • Kuwait
  • Infectious Disease Diagnostics Market Forecast by Test
  • Kuwait
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • Kuwait
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • Lebanon
  • Microbiology Specimen Volume Forecast by Type
  • Lebanon
  • Microbiology Test Volume Forecasts by Application
  • Lebanon
  • Microbiology Consumables Market Forecast by Application
  • Lebanon
  • Infectious Disease Test Volume Forecast by Assay
  • Lebanon
  • Infectious Disease Diagnostics Market Forecast by Test
  • Lebanon
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • Lebanon
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • Oman
  • Microbiology Specimen Volume Forecast by Type
  • Oman
  • Microbiology Test Volume Forecasts by Application
  • Oman
  • Microbiology Consumables Market Forecast by Application
  • Oman
  • Infectious Disease Test Volume Forecast by Assay
  • Oman
  • Infectious Disease Diagnostics Market Forecast by Test
  • Oman
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • Oman
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • Qatar
  • Microbiology Specimen Volume Forecast by Type
  • Qatar
  • Microbiology Test Volume Forecasts by Application
  • Qatar
  • Microbiology Consumables Market Forecast by Application
  • Qatar
  • Infectious Disease Test Volume Forecast by Assay
  • Qatar
  • Infectious Disease Diagnostics Market Forecast by Test
  • Qatar
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • Qatar
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • Saudi Arabia
  • Microbiology Specimen Volume Forecast by Type
  • Saudi Arabia
  • Microbiology Test Volume Forecasts by Application
  • Saudi Arabia
  • Microbiology Consumables Market Forecast by Application
  • Saudi Arabia
  • Infectious Disease Test Volume Forecast by Assay
  • Saudi Arabia
  • Infectious Disease Diagnostics Market Forecast by Test
  • Saudi Arabia
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • Saudi Arabia
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • United Arab Emirates
  • Microbiology Specimen Volume Forecast by Type
  • United Arab Emirates
  • Microbiology Test Volume Forecasts by Application
  • United Arab Emirates
  • Microbiology Consumables Market Forecast by Application
  • United Arab Emirates
  • Infectious Disease Test Volume Forecast by Assay
  • United Arab Emirates
  • Infectious Disease Diagnostics Market Forecast by Test
  • United Arab Emirates
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • United Arab Emirates
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • Major Companies Developing or Marketing AIDS Tests
  • Major Companies Developing or Marketing Adenovirus Tests
  • Major Companies Developing or Marketing Bartonella Tests
  • Major Companies Developing or Marketing Campylobacter Tests
  • Major Companies Developing or Marketing Candida Tests
  • Major Companies Developing or Marketing Chlamydia Tests
  • Major Companies Developing or Marketing Clostridium Tests
  • Major Companies Developing or Marketing Coronavirus Tests
  • Major Companies Developing or Marketing Cryptosporidium Tests
  • Major Companies Developing or Marketing CMV Tests
  • Major Companies Developing or Marketing Echovirus Tests
  • Major Companies Developing or Marketing Enterovirus Tests
  • Major Companies Developing or Marketing EBV Tests
  • Major Companies Developing or Marketing Giardia Tests
  • Major Companies Developing or Marketing Gonorrhea Tests
  • Major Companies Developing or Marketing Hantavirus Tests
  • Major Companies Developing or Marketing Helicobacter Pylori Tests
  • Major Companies Developing or Marketing Hepatitis Tests
  • Major Companies Developing or Marketing Herpes Tests
  • Major Companies Developing or Marketing Influenza Tests
  • Major Companies Developing or Marketing Legionella Tests
  • Major Companies Developing or Marketing Lyme Disease Tests
  • Major Companies Developing or Marketing Lymphogranuloma Tests
  • Major Companies Developing or Marketing Malaria Tests
  • Major Companies Developing or Marketing Measles Tests
  • Major Companies Developing or Marketing Meningitis Tests
  • Major Companies Developing or Marketing Microsporidium Tests
  • Major Companies Developing or Marketing Mononucleosis Tests
  • Major Companies Developing or Marketing Mumps Tests
  • Major Companies Developing or Marketing Mycoplasma Tests
  • Major Companies Developing or Marketing Papilloma Virus Tests
  • Major Companies Developing or Marketing Parvovirus Tests
  • Major Companies Developing or Marketing Pneumonia Tests
  • Major Companies Developing or Marketing RSV Tests
  • Major Companies Developing or Marketing Rotavirus Tests
  • Major Companies Developing or Marketing Rubella Tests
  • Major Companies Developing or Marketing Salmonella Tests
  • Major Companies Developing or Marketing Septicemia Tests
  • Major Companies Developing or Marketing Shigella Tests
  • Major Companies Developing or Marketing Staphylococci Tests
  • Major Companies Developing or Marketing Streptococci Tests
  • Major Companies Developing or Marketing Syphilis Tests
  • Major Companies Developing or Marketing Toxoplasmosis Tests
  • Major Companies Developing or Marketing Trichomonas Tests
  • Major Companies Developing or Marketing Tuberculosis Tests
  • Major Companies Developing or Marketing West Nile Tests
  • Major Companies Developing or Marketing Yersinia Tests
Back to Top